Form 8-K - Current report:
SEC Accession No. 0001601485-26-000026
Filing Date
2026-03-12
Accepted
2026-03-12 16:08:43
Documents
20
Period of Report
2026-03-12
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K angn-20260312.htm   iXBRL 8-K 25558
2 EX-99.1 elicioq425prdraft_31226.htm EX-99.1 18255
6 elicioq425prdraft_31226001.jpg GRAPHIC 200181
7 elicioq425prdraft_31226002.jpg GRAPHIC 202164
8 elicioq425prdraft_31226003.jpg GRAPHIC 176540
9 elicioq425prdraft_31226004.jpg GRAPHIC 207455
10 elicioq425prdraft_31226005.jpg GRAPHIC 227137
11 elicioq425prdraft_31226006.jpg GRAPHIC 269616
12 elicioq425prdraft_31226007.jpg GRAPHIC 172432
  Complete submission text file 0001601485-26-000026.txt   2176101

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20260312.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20260312_lab.xml EX-101.LAB 22516
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20260312_pre.xml EX-101.PRE 13037
23 EXTRACTED XBRL INSTANCE DOCUMENT angn-20260312_htm.xml XML 3010
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 26747732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)